Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Olopatadine HCl Nasal Spray in Children with Seasonal Allergic Rhinitis
NCT00578929Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Sep 2007
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olopatadine in seasonal allergic rhinitis (SAR), sponsored by Alcon Inc.. Started Sep 2007; status: completed.
02
Drugs
olopatadine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00578929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00578929.